- JP-listed companies
- RaQualia Pharma Inc.
- Balance sheet
RaQualia Pharma Inc.【JP:4579】Balance sheet
Market cap
¥22.3B
P/E ratio
-313.5x
| 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | - | 1,891 | 1,840 | 1,428 | 2,268 | 1,671 | 2,174 | 1,394 | 2,345 | 3,675 | 3,715 | 3,340 |
| Marketable securities, current | - | 1,184 | 503 | 9 | 329 | 168 | 26 | 719 | 314 | 251 | 50 | 2 |
| Accounts receivable, net | - | - | - | - | - | - | - | - | - | 602 | 603 | 689 |
| Total current assets | - | 3,261 | 2,708 | 1,806 | 3,322 | 1,962 | 3,067 | 2,834 | 4,004 | 4,822 | 4,957 | 4,539 |
| Property, plant and equipment, net | - | 85 | 261 | 249 | 216 | 318 | 249 | 333 | 299 | 391 | 574 | 529 |
| Marketable securities, non-current | - | 1,800 | 1,752 | 1,937 | 1,503 | 1,717 | 1,474 | 1,038 | 888 | 988 | 1,231 | 547 |
| Total non-current assets | - | 1,941 | 2,044 | 2,213 | 1,742 | 2,090 | 1,769 | 1,417 | 1,230 | 1,436 | 1,915 | 5,117 |
| Total assets | - | 5,202 | 4,752 | 4,019 | 5,064 | 4,052 | 4,837 | 4,251 | 5,234 | 6,258 | 6,872 | 9,655 |
| Long-term debt, current | - | - | - | - | - | - | - | - | - | 3 | 13 | 513 |
| Total current liabilities | - | 262 | 200 | 190 | 149 | 164 | 183 | 187 | 401 | 494 | 389 | 1,187 |
| Long-term debt, non-current | - | - | - | - | - | - | - | - | - | 9 | 39 | 2,651 |
| Total non-current liabilities | - | 109 | 38 | 41 | 27 | 31 | 33 | 53 | 46 | 267 | 362 | 2,897 |
| Total liabilities | - | 371 | 238 | 231 | 176 | 195 | 216 | 240 | 446 | 761 | 752 | 4,085 |
| Common stock and paid-in capital | - | 13,189 | 14,896 | 4,475 | 5,672 | 5,777 | 4,700 | 4,701 | 4,704 | 4,721 | 5,525 | 5,631 |
| Retained earnings | - | -8,567 | -10,421 | -728 | -786 | -1,890 | -99 | -706 | 50 | 773 | 449 | -46 |
| Stockholders' equity | 5,717 | 4,831 | 4,514 | 3,788 | 4,888 | 3,857 | 4,621 | 4,011 | 4,788 | 5,497 | 6,120 | 5,571 |